Childhood Cancer Incidence, New York State, 2016-2020
Source: New York State Cancer Registry
| Site of Cancer | Ages 0-4 | Ages 5-9 | Ages 10-14 | Ages 15-19 | Combined Ages 0-14 | Combined Ages 0-19 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Avg Annual Cases | Rate per 1,000,000 | Avg Annual Cases | Rate per 1,000,000 | Avg Annual Cases | Rate per 1,000,000 | Avg Annual Cases | Rate per 1,000,000 | Avg Annual Cases | Rate per 1,000,000 | 95% CI | Avg Annual Cases | Rate per 1,000,000 | 95% CI | |
| All Invasive Malignant Tumors | 278.4 | 243.9 | 152.8 | 136.2 | 209.8 | 188.1 | 334.8 | 282.0 | 641.0 | 188.5 | 182.0-195.2 | 975.8 | 212.0 | 206.1-218.1 |
| I Leukemias, myeloproliferative and myelodysplastic diseases | 89.2 | 78.1 | 44.0 | 39.2 | 42.8 | 38.4 | 51.4 | 43.3 | 176.0 | 51.5 | 48.1-55.0 | 227.4 | 49.4 | 46.6-52.4 |
| I(a) Lymphoid leukemias | 66.0 | 57.8 | 36.2 | 32.3 | 25.4 | 22.8 | 25.2 | 21.2 | 127.6 | 37.3 | 34.4-40.3 | 152.8 | 33.2 | 30.9-35.7 |
| I(b) Acute myeloid leukemia | 14.8 | 13.0 | 3.8 | 3.4 | 10.2 | 9.1 | 15.6 | 13.1 | 28.8 | 8.4 | 7.1-9.9 | 44.4 | 9.6 | 8.4-11.0 |
| II Lymphomas and reticuloendothelial neoplasms | 21.6 | 18.9 | 24.6 | 21.9 | 36.6 | 32.8 | 75.6 | 63.7 | 82.8 | 24.7 | 22.3-27.2 | 158.4 | 34.5 | 32.1-37.0 |
| II(a) Hodgkin lymphoma | 1.2 | 1.1 | 2.8 | 2.5 | 15.0 | 13.5 | 46.2 | 38.9 | 19.0 | 5.8 | 4.7-7.0 | 65.2 | 14.1 | 12.6-15.7 |
| II(b,c,d) Non-Hodgkin lymphomas | 20.2 | 17.7 | 21.8 | 19.4 | 21.6 | 19.4 | 28.8 | 24.3 | 63.6 | 18.8 | 16.8-21.0 | 92.4 | 20.2 | 18.4-22.1 |
| III CNS & misc intracranial & intraspinal neoplasms | 49.6 | 43.4 | 41.6 | 37.1 | 39.0 | 35.0 | 26.0 | 21.9 | 130.2 | 38.4 | 35.5-41.5 | 156.2 | 34.3 | 31.9-36.7 |
| III(a) Ependymomas and choroid plexus tumor | 6.6 | 5.8 | 2.6 | 2.3 | 1.4 | 1.3 | 1.8 | 1.5 | 10.6 | 3.1 | 2.3-4.0 | 12.4 | 2.7 | 2.1-3.4 |
| III(b) Astrocytoma | 22.0 | 19.3 | 22.0 | 19.6 | 20.4 | 18.3 | 14.8 | 12.5 | 64.4 | 19.1 | 17.0-21.3 | 79.2 | 17.4 | 15.7-19.2 |
| III(c) Intracranial and intraspinal embryonal tumors | 13.0 | 11.4 | 7.4 | 6.6 | 6.0 | 5.4 | 2.2 | 1.9 | 26.4 | 7.7 | 6.5-9.2 | 28.6 | 6.2 | 5.3-7.4 |
| III(d) Other gliomas | 6.0 | 5.3 | 8.6 | 7.7 | 10.0 | 9.0 | 5.8 | 4.9 | 24.6 | 7.3 | 6.1-8.7 | 30.4 | 6.7 | 5.7-7.9 |
| IV Neuroblastoma and other peripheral nervous cell tumors | 38.6 | 33.8 | 6.6 | 5.9 | 1.2 | 1.1 | 1.2 | 1.0 | 46.4 | 13.2 | 11.6-15.0 | 47.6 | 10.2 | 8.9-11.5 |
| IV(a) Neuroblastoma and ganglioneuroblastoma | 38.6 | 33.8 | 6.6 | 5.9 | 0.8 | 0.7 | 0.8 | 0.7 | 46.0 | 13.1 | 11.5-14.9 | 46.8 | 10.0 | 8.7-11.3 |
| V Retinoblastoma | 16.2 | 14.2 | 0.4 | 0.4 | 0.2 | 0.2 | 0.2 | 0.2 | 16.8 | 4.7 | 3.8-5.9 | 17.0 | 3.6 | 2.9-4.4 |
| VI Renal tumors | 22.8 | 20.0 | 6.0 | 5.3 | 3.2 | 2.9 | 2.4 | 2.0 | 32.0 | 9.2 | 7.8-10.8 | 34.4 | 7.4 | 6.3-8.6 |
| VI(a) Nephroblastoma and other nonepithelial renal tumor | 22.8 | 20.0 | 5.6 | 5.0 | 1.2 | 1.1 | 0.0 | 0.0 | 29.6 | 8.5 | 7.2-10.0 | 29.6 | 6.3 | 5.4-7.5 |
| VII Hepatic tumors | 8.8 | 7.7 | 1.0 | 0.9 | 0.6 | 0.5 | 2.2 | 1.9 | 10.4 | 3.0 | 2.2-3.9 | 12.6 | 2.7 | 2.1-3.4 |
| VII(a) Hepatoblastoma and mesenchymal tumors of liver | 8.4 | 7.4 | 0.8 | 0.7 | 0.0 | 0.0 | 0.2 | 0.2 | 9.2 | 2.6 | 1.9-3.5 | 9.4 | 2.0 | 1.5-2.7 |
| VIII Malignant bone tumors | 1.4 | 1.2 | 6.8 | 6.1 | 21.6 | 19.4 | 24.8 | 20.9 | 29.8 | 9.0 | 7.6-10.6 | 54.6 | 12.0 | 10.6-13.5 |
| VIII(a) Osteosarcoma | 0.0 | 0.0 | 3.2 | 2.9 | 13.8 | 12.4 | 13.4 | 11.3 | 17.0 | 5.2 | 4.1-6.4 | 30.4 | 6.7 | 5.7-7.9 |
| VIII(c) Ewing tumor and related sarcomas of bone | 0.8 | 0.7 | 3.0 | 2.7 | 6.2 | 5.6 | 7.2 | 6.1 | 10.0 | 3.0 | 2.2-4.0 | 17.2 | 3.8 | 3.0-4.7 |
| IX Soft tissue and other extraosseous sarcomas | 16.6 | 14.5 | 10.6 | 9.4 | 17.2 | 15.4 | 23.2 | 19.5 | 44.4 | 13.1 | 11.4-15.0 | 67.6 | 14.7 | 13.2-16.4 |
| IX(a) Rhabdomyosarcoma | 10.2 | 8.9 | 5.2 | 4.6 | 5.4 | 4.8 | 6.8 | 5.7 | 20.8 | 6.1 | 5.0-7.4 | 27.6 | 6.0 | 5.0-7.1 |
| X Germ cell & trophoblastic tumors & gonadal neoplasms | 8.2 | 7.2 | 5.0 | 4.5 | 10.2 | 9.1 | 30.4 | 25.6 | 23.4 | 6.9 | 5.7-8.3 | 53.8 | 11.6 | 10.3-13.1 |
| X(a) Intracranial and intraspinal germ cell tumor | 1.4 | 1.2 | 1.4 | 1.2 | 4.2 | 3.8 | 2.6 | 2.2 | 7.0 | 2.1 | 1.5-2.9 | 9.6 | 2.1 | 1.6-2.8 |
| X(c) Malignant gonadal germ cell tumor | 2.0 | 1.8 | 3.0 | 2.7 | 5.6 | 5.0 | 22.8 | 19.2 | 10.6 | 3.2 | 2.4-4.2 | 33.4 | 7.2 | 6.2-8.4 |
| XI Other malignant epithelial neoplasms and malignant melanomas | 3.0 | 2.6 | 5.4 | 4.8 | 36.0 | 32.3 | 95.6 | 80.5 | 44.4 | 13.5 | 11.7-15.3 | 140.0 | 30.3 | 28.1-32.7 |
| XI(b) Thyroid carcinoma | 0.8 | 0.7 | 1.4 | 1.2 | 15.4 | 13.8 | 56.4 | 47.5 | 17.6 | 5.3 | 4.3-6.6 | 74.0 | 16.0 | 14.4-17.7 |
| XI(d) Malignant melanoma | 1.4 | 1.2 | 0.8 | 0.7 | 2.8 | 2.5 | 6.4 | 5.4 | 5.0 | 1.5 | 1.0-2.2 | 11.4 | 2.5 | 1.9-3.2 |
| XII Other and unspecified malignant neoplasms | 2.0 | 1.8 | 0.8 | 0.7 | 0.8 | 0.7 | 1.8 | 1.5 | 3.6 | 1.0 | 0.6-1.7 | 5.4 | 1.2 | 0.8-1.7 |
Notes
- Incidence data are provisional, November 2022.
- Rates are per 1,000,000 children. Rates for 0-14 and 0-19 year age intervals are age-adjusted within these intervals to the 2000 US standard population, with 95% confidence intervals.
- Rates based on fewer than 4 cases per year are unstable and should be used with caution.
- Non-Hodgkin lymphomas, Burkitt, and miscellaneous lymphomas are grouped together under II(b,c,d).
